Bronchoscopic, photodynamic, and laser diagnosis and therapy of lung neoplasms

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 4, 1996, Pages 271-276

  Lam, Stephen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT;

BRACHYTHERAPY; BRONCHOSCOPY; BRONCHUS TUMOR; ENDOSCOPY; HUMAN; LASER; LASER SURGERY; LIGHT; LUNG TUMOR; MESOTHELIOMA; PALLIATIVE THERAPY; PHOTOCHEMOTHERAPY; PLEURA TUMOR; REVIEW; STENT; TRACHEA TUMOR;

BRACHYTHERAPY; BRONCHIAL NEOPLASMS; BRONCHOSCOPY; ENDOSCOPY; HUMANS; LASER SURGERY; LASERS; LIGHT; LUNG NEOPLASMS; MESOTHELIOMA; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PLEURAL NEOPLASMS; STENTS; TRACHEAL NEOPLASMS;

EID: 0030178340     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Philipp CM, Rohde E, Berlien HP: Nd:YAG laser procedures in tumor treatment. Semin Surg Oncol 1995, 11:290-298.
2. Fisher AM, Murphree AI, Gomer CJ: Clinical and preclinical photodynamic therapy. Lasers Surg Med 1995, 17:2-31. A good overview of photosensitizers, photochemistry, photobiology, lasers involved in PDT, dosimetry, and clinical results.
3. Keller SM: Photodynamic therapy biology and clinical application. Chest Surg Clin North Am 1995, 5:121-137.
4. Strong MS, Vaughan CW, Polanyi T, Wallace R: Bronchoscopic carbon dioxide laser surgery. Ann Otol Rhinol Laryngol 1974, 83:769-776.
5. LaForet EG, Berger RL, Vaughan CW: Carcinoma obstructing the trachea: treatment by laser resection [letter]. N Engl J Med 1976, 294:941.
6. Waller DA, Gower A, Kashyap AP, Conacher ID, Morritt GN: Carbon dioxide laser bronchoscopy: a review of its use in the treatment of malignant tracheobronchial tumors in 142 patients. Respir Med 1994, 88:737-741.
7. Courey MS, Ossoff RH: Carbon dioxide laser bronchoscopy. In Minimally Invasive Techniques in Thoracic Medicine and Surgery. Edited by Hetzel M. London: Chapman & Hall; 1995:81-91.
8. Toty L, Personne C, Colchen A, et al.: Bronchoscopic management of tracheal lesions using the neodymium yttrium aluminum garnet laser. Thorax 1981, 36:175-178.
9. Dumon JF, Reboud E, Garbe L, Aucomte F, Meric B: Treatment of tracheobronchial lesions by laser photoresection. 1982, 81:278-284.
10. Dumon IF, Shapshay S, Bourcereau J, et al.: Principles for safety in application of neodymium-yttrium laser in bronchology. Chest 1984, 86:163-168.
11. Hetze MR: Nd-YAG laser bronchoscopy: fiberoptic and rigid bronchoscopy techniques. In Minimally Invasive Techniques in Thoracic Medicine and Surgery. Edited by Hetzel MR. London: Chapman & Hall; 1995:63-79. The practical aspects of laser bronchoscopy are outlined.
12. Cavaliere S, Foccoli P, Toninelli C, Feijo S: Nd:YAG laser therapy in lung cancer: an 11-year experience with 2,253 applications in 1,585 patients. J Bronchology 1994, 1:105-111.
13. Hetzel MR: Outcome, morbidity and mortality of Yd:YAG laser photoresection. In Minimally Invasive Techniques in Thoracic Medicine and Surgery. Edited by Hetzel MR. London: Chapman & Hall; 1995:137-146. A summary of 21 reported series published since 1980 by groups who pioneered this treatment modality and other series that have either involved a large experience or that have attempted careful objective monitoring.
14. Clarke CP, Ball DL, Sephton R: Follow-up of patients having Nd:YAG laser resection of bronchostenotic lesions. J Bronchology 1994, 1:19-22.
15. Zwirewich CV, Muller NL, Lam SC: Photodynamic laser therapy to alleviate complete bronchial obstruction: comparison of CT and bronchoscopy to predict outcome. AJR Am J Roentgenol 1988, 151:897-901.
16. Lam S, Muller NL, Miller RR, et al.: Laser treatment of obstructive endobronchial tumors: factors which determine response. Lasers Med Surg 1987, 7:29-35.
17. Lam S, Becker HD: Future diagnostic procedures. Chest Surg Clin North Am 1996, 6:363-380.
18. Becker HD: Stenting of the central airways. J Bronchology 1995, 2:98-106. A good review of the indications, technique, clinical results, and complications of stent placement in 95 patients.
19. Dumon JF: A dedicated tracheobronchial stent Chest 1990, 97:328-332.
20. Rousseau H, Dahan M, Lauque D: Self-expandable prostheses in the tracheobronchial tree. Radiology 1993, 188:199-202.
21. Vinograd I, Klin B, Brosh T, Weinberg M, Flomenblit Y, Nevo Z: A new intratracheal stent made from nitinol, an alloy with "shape memory effect." J Thorac Cardiovasc Surg 1994, 107:1255-1261.
22. Bolliger CT, Arnoux A, Oeggerli MV, Lukic G, Perruchoud AP: Covered wallstent insertion in a patient with conical tracheobronchial stenosis. J Bronchology 1995, 2:215-218.
23. Freitag L, Eicker K, Donovan TJ, Dimov D: Mechanical properties of airway stents. J Bronchology 1995, 2:270-278.
24. Sutedja G, Schramel van KK, Postmus PE: Stent placement is justifiable in end-stage patients with malignant airway tumours. Respiration 1995, 62:148-150.
25. Lam S: Photodynamic therapy of lung cancer. Semin Oncol 1994, 6:15-19. A review of published reports and the author's own experience in the use of PDT as a curative treatment for early lung cancer and as a palliative treatment for advanced inoperative obstructive bronchial tumors
26. Dougherty TJ, Cooper MT, Mang TS: Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med 1990, 10:485-488.
27. Sutedja G, van Kralingen K, Schramel F, Postmus PE: Fiberoptic bronchoscopic electrosurgery under local anaesthesia for rapid palliation in patients with central airway malignancies: a preliminary report Thorax 1994, 49:1243-1246.
28. Shea JM, Allen RP, Tharratt RS, Chan AL, Siefkin AD: Survival of patients undergoing Nd:YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease. Chest 1993, 103:1028-1031.
29. Wong E, Lam S, Graflon C, Wong F, Morris J, McKenzie M, Goddard K, Yuen K: HDR brachytherapy for obstructive bronchial tumors. J Bronchology 1994, 1:99-104.
30. Speiser BL, Spratling L: Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiation Oncol Biol Phys 1995, 25:579-587.
31. Alberti WE: Endobronchial high dose rate brachytherapy. Int J Radiation Oncol Biol Phys 1995, 25:753-777.
32. Chang LFL, Horvath J, Peyton W, Ling SS: High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Int J Radiation Oncol Biol Phys 1995, 28:589-596.
33. Speiser BL, Spratling L: Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation. Int J Radiation Oncol Biol Phys 1995, 25:589-597.
34. George PJM: Assessment of the response to laser resection. In Minimally Invasive Techniques in Thoracic Medicine and Surgery. Edited by Hetzel MR. London: Chapman & Hall; 1995:105-121. Methods to quantify the symptomatic and lung function improvement are described. The importance of documenting the efficacy of laser therapy is stressed.
35. Sutedja TG, Schreurs AJ, Vanderschueren RG, Kwa B, van den Werf TS, Postmus PE: Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid. Chest 1995, 107:556-558. An interesting study in eleven patients with endobronchial typical carcinoids showing no evidence of recurrent tumor after Nd:YAG laser resection or simply mechanical removal with a median follow-up of 47 months. Six patients who had surgery after bronchoscopic therapy did not show any evidence of residual tumor.
36. Pass HI, DeLaney TF, Tochner Z, Smith PE, Temek BK, Pogrebniak HW, Kranda KC, Russo A, Friauf WS, Cole JW, et al.: Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol 1994, 11:28-37.
37. Pass HI, Donington JS: Use of photodynamic therapy for the management of pleural malignancies. Semin Surg Oncol 1995, 11:360-367. A review of the preclinical work and phase I and II clinical trial results leading to the development of a phase III clinical trial protocol.
38. Takita H, Dougherty TJ: Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 1995, 11:368-371. The results of a phase II clinical trial showing an estimated median survival of 21 months following debulking surgery and intracavitary PDT in patients with stage I or II malignant pleural mesothelioma.
39. Furuse K, Fukuoka M, Kato H, et al.: A prospective phase II study of photodynamic therapy with photofrin II for centrally located early-stage lung cancer. J Clin Oncol 1993, 11:1852-1857.
40. Kato H, Okunaka T: Photodynamic therapy in early tumors: combined use of photodynamic therapy and surgery. In Minimally Invasive Techniques in Thoracic Medicine and Surgery. Edited by Hetzel MR. London: Chapman & Hall; 1995:149-171. A review of the extensive experience of PDT in both early and advanced lung cancer in Japan by a pioneering group.
41. Cortese DA: Bronchoscopic photodynamic therapy of radiologically occult lung cancer: the American experience. In Minimally Invasive Techniques in Thoracic Medicine and Surgery. Edited by Hetzel MR. London: Chapman & Hall; 1995:173-178. This review of the PDT experience at the Mayo Clinic made reference to an important study that showed that PDT may be an alternative to surgery in a small subset of patients with superficial squamous carcinoma less than 1 cm in surface diameter.
42. Sutedja T, Lam S, LeRiche JC, Postmus PE: Response and pattern of failure after photodynamic therapy for intraluminal stage I lung cancer. J Bronchology 1994, 1:295-298.
43. Lam S, Profio AE: Fluorescence tumor detection. In Minimally Invasive Techniques in Thoracic Medicine and Surgery. Edited by Hetzel MR. London: Chapman & Hall; 1995:179-191. A comprehensive review of the rationale behind fluorescence bronchoscopy, instrumentation, and clinical results.
44. Braichotte DR, Wagnjères GA, Bays R, Monnier P, van den Bergh HE: Clinical pharmacokinetic studies of Photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi. Cancer 1995, 75:2768-2778.
45. Qu J, MacAulay C, Lam S, Palcic B: Optical properties of normal and carcinoma bronchial tissue. Appl Opt 1994, 33:7397-7405.
46. Qu J, MacAulay C, Lam S, Palcic B: Laser-induced fluorescence spectroscopy at endoscopy: tissue optics, Monte Carlo modeling, and in vivo measurements. Opt Eng 1995, 34:3334-3343. The optical properties and fluorescence characteristics of normal, dysplastic, and malignant bronchial tissues were measured in vitro and in vivo. Changes in fluorescence intensity were found to be more robust for detecting abnormal tissues than the differences in spectral shape.
47. Lam S, MacAulay C, LeRiche JC, Ikeda N, Palcic B: Early localization of bronchogenic carcinoma. J Diagn Ther Endosc 1994, 1:75-78.
48. Lee FYW, Ng AWK, Wang YT: Early detection of lung cancer with the LIFE laser [abstract]. Chest 1995, 108:151.
49. Thieberville L, Payne P, Vielkinds J, LeRiche J, Horsman D, Nouvet G, Palcic B, Lam S: Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 1995, 55:5133-5139. Fluorescence bronchoscopy was used to localize preinvasive bronchial lesions for biopsy and molecular genetics studies. This study showed that progression of premalignant epithelial lesions to carcinoma was associated with cumulative gene losses. Fluorescence bronchoscopy provides an important tool to study the pathogenesis of lung cancer and the effect of various interventions such as chemoprevention.